Hebei Changshan Biochemical Pharmaceutical Co. Ltd Financials

Market Capitalization CN¥18.62 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	-13.89
Forward PE
Price to Sales TTM	CN¥17.65
Price to Book MRQ	CN¥10.24
Enterprise to Revenue	19.65
Enterprise to EBITDA	-24.26

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	-80.07%
Operating Margin	3.07%
Return on Assets TTM	-11.64%
Return on Equity TTM	-39.82%

Income Statement

Revenue TTM	CN¥1,054,846,144
Revenue per Share TTM	CN¥1.37
Quarterly Revenue Growth	-32.30%
Gross Profit TTM	CN¥317,377,204
EBITDA	CN¥-854,456,960
Net Income to Common TTM	CN¥-844,590,208
Diluted EPS TTM	CN¥-0.92
Quarterly Earnings Growth YoY	-32.26%

Balance Sheet

Total Cash MRQ	CN¥314,222,880
Total Cash per Share MRQ	CN¥0.34
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	132.16
Current Ratio MRQ	1.14
Book Value per Share MRQ	CN¥1.98

Cash Flow

Operating Cash Flow TTM	CN¥307,433,088
Levered Free Cash Flow TTM	CN¥305,736,640

300255 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	919,060,992
Float Shares	499,160,344
Avg 10 Volume	30,870,299
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	47.73%
% Held by Institutions	0.33%

Stock Price Summary

Beta	0.05
Fifty Two Week Low	CN¥7.56
Fifty Two Week High	CN¥25.88
Fifty Two Week Change	43.31%
Day 50 MA	CN¥19.54
Day 200 MA	CN¥12.79

Dividends and Splits

Forward Annual Dividend Rate	CN¥0.01
Forward Annual Dividend Yield	0.05%
Trailing Annual Dividend Rate	CN¥0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date	2023-06-27
Last Split Factor
Last Split Date	2016-04-20